Sodium-glucose cotransporter-2 inhibitors may decrease incidence of recurrent gout flares
1. Over a one-year period, the incidence of recurrent gout flares in patients with gout and diabetes was significantly lower ...
Tag: allopurinol
Allopurinol does not reduce cardiovascular risk for patients with ischemic heart disease without gout
1. The composite score for non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death was comparable between allopurinol (11.0%) and usual ...
Allopurinol does not increased mortality in gout and chronic kidney disease patients
1. In patients with gout and chronic kidney disease, the initiation of allopurinol was not associated with increased mortality. 2. ...
Febuxostat is not associated with worse cardiovascular safety outcomes or all-cause mortality compared to allopurinol
1. Febuxostat was non-inferior to allopurinol for primary cardiovascular endpoints including hospitalization for non-fatal myocardial infarction or biomarker-positive acute coronary ...
Kidney function in type 1 diabetes does not benefit from allopurinol therapy
1. Serum urate reduction with allopurinol was not shown to clinically benefit kidney function among patients with type 1 diabetes ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
